Adenovirus-mediated Smad4 gene transfer inhibit.s tumor growth and metastasis of human pancreatic carcinoma
Adenovirus-mediated Smad4 gene transfer inhibit.s tumor growth and metastasis of human pancreatic carcinoma
批准号:
14571211
负责人:
NAGAI Eishi
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
胰腺癌是最难治愈的肿瘤之一,因为它具有高度的侵袭性和转移性。我们之前生成了一个拮抗剂。霍夫在胰腺癌的侵袭和转移中起重要作用。这种HGF拮抗剂,NK 4对HGF与C-MET受体的相互作用具有竞争性抑制作用。此外,NK 4抑制不同细胞的增殖和迁移。血管生成因子刺激的内皮细胞类型。在我们的前期研究中,腺病毒介导的NK 4基因治疗抑制了高表达c-MET的人胰腺癌细胞系的生长、侵袭和转移。然而,有一些胰腺癌细胞系具有低水平的c-MET表达,因此我们将重点放在Smad 4/DPC 4上。SMAD 4是信号转导途径中的关键辅因子,其响应于转化生长因子-β(TGF-β)相关配体而被激活,调节细胞生长和分化。据报道,Smad 4表达对胰腺肿瘤侵袭和血管生成的抑制作用。腺病毒介导的SMAD 4基因转移在一组SMAD 4纯合子筛选的人胰腺癌细胞系中可恢复SMAD 4蛋白的表达和功能。因此腺病毒介导的Smad 4基因治疗可能是胰腺癌治疗的另一个有吸引力的选择。我们现在正在制备用于胰腺癌细胞系的细胞生长和侵袭力的重组腺病毒。将分析腺病毒-NK 4感染的胰腺癌细胞在裸鼠中的肿瘤生长。
英文摘要
Pancreatic cancer is one, of the most difficult neoplasms to treat curatively, because of its highly invasive and metastatic potential. We previously generated an antagonist. for HOF which played an important role in invasion and metastasis of human pancreatic cancer. This HGF-antagonist., NK4 has competitive inhibitory effects on interaction between HGF and C-MET receptor. Furthermore, NK4 inhibits proliferation and migration of distinct. type of endotbelial cells stimulated by angiogenic factor. In our privios study, adnovirus-mediated NK4 gene therapy suppressed the growth, invasiveness and metastasis of human pancreatic cancer cell lines with high expression of c-MET. However, there are a few pancreatic cancer cell lines with low level of c-MET expression, so we focused on Smad 4/DPC4. SMAD4 is a critical cofactor in signal transduction pathways activated in response to transforming growth factor-beta (TGF-beta)-related ligands, regulating cell growth and differentiation. Smad4 has been reported to express the inhibitory effects of on pancreatic tumour invasion and angiogenesis. Adenovirus mediated gene transfer in a panel of SMAD4 homozygouscleleted human pancreatic tumor cell lines should restore SMAD4 protein ex-pression and function. Thus adenovirus mediated Smad 4 gene therapy may be another attractive option for the treatment of pancreatic cancer. We are now preparing recombinat aclenovirus for cell growth and invasiveness of pancreatic cancer cell lines. The tumor growth of adenovirus-NK4 infected pancreatic cancer cells in nude mice will be analyzed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of pancreatic cancer metastasis-promoting microenvironment induced by neutrophil extracellular traps
-
批准号:18K08685
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2018
-
负责人:NAGAI Eishi
-
依托单位:
A novel treatment of pancreatic cancer through microRNA management using a drug delivery system by artificial virus.
-
批准号:15K15498
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2015
-
负责人:NAGAI Eishi
-
依托单位:
Refractory cancer therapy development by cancer microenvironment elucidation and new drug delivery system based on autophagy
-
批准号:25293287
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2013
-
负责人:NAGAI Eishi
-
依托单位:
Development of novel therapies that focus on autophagy-induced cancer cell substrate clearance function
-
批准号:25670587
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:NAGAI Eishi
-
依托单位:
The development of pancreatic cancer therapy based on regulating pancreatic cancer desmoplasia by targeting pancreatic stellate cells to improve drug delivery
-
批准号:23659652
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.25万
-
财政年份:2011
-
负责人:NAGAI Eishi
-
依托单位:
Investigation the mechanism and the role of RNA activation by micro RNA in pancreatic cancer
-
批准号:22390258
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2010
-
负责人:NAGAI Eishi
-
依托单位:
Quantitative and functional analysis of mRNA using formalin fixedparaffin embedded samples of IPMN -Innovation for new treatmentof IPMN-
-
批准号:19591593
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:NAGAI Eishi
-
依托单位:
Quantitative analysis of mRNA of Intraductal papillary mucinous neoplasms: To differentiate carcinoma from benign neoplasms
-
批准号:17591412
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:NAGAI Eishi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
UFM1 介导 SNIP1 的 UFMylation 修饰通过抑制SMAD4/P300 复合物形成调控椎间盘退变的机制研究
-
批准号:ZCLQN26H0602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:沈潘洋
-
依托单位:
HDAC4通过TGF-β/SMAD4通路影响胶质瘤侵袭转移的机制研究
-
批准号:HZQN25H160004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:阮杭泽
-
依托单位:
TGFβ效应分子Smad4抑制促进肺癌肝转移的机制研究
-
批准号:HZQN25H160002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黄杰
-
依托单位:
TGF-β1/SMAD4/miR-184正反馈环路抑制梅山猪卵泡闭锁的机制探究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李琦琦
-
依托单位:
组蛋白乙酰转移酶 HAT1 通过增强 CTHRC1/SMAD4/IL-10 信号轴促进 CD8+T
淋巴细胞终末耗竭分化在肺腺癌 PD-1 单抗耐药中的机制研究
-
批准号:24ZR1446400
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:韩逸超
-
依托单位:
SMAD4泛素化修饰调控人卵巢癌细胞凋亡的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
CD24介导中性粒细胞SMAD4核心转录调控网络重构抑制
NETs保护儿童肾缺血再灌注损伤的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
基于骨骼肌卫星细胞β-catenin/c-Jun/Smad4轴研究健脾补肾方促进骨质疏松性骨折愈合的作用机制
-
批准号:82305262
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:金镇雄
-
依托单位:
miR-431/Smad4调控阿尔茨海默病突触可塑性的机制研究及临床转化
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
SMAD4基因MH2域突变导致非小细胞肺癌对奥希替尼耐药的作用及机制探究
-
批准号:82303894
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王静
-
依托单位: